• United States

U.S. Pharma Stocks Analysis

NasdaqGS:JAZZ
NasdaqGS:JAZZ
NasdaqGS:JAZZPharmaceuticals

Trade Alert: The Senior VP & Chief Accounting Officer Of Jazz Pharmaceuticals plc (NASDAQ:JAZZ), Patricia Carr, Has Sold Some Shares Recently

May 14, 2022
We'd be surprised if Jazz Pharmaceuticals plc ( NASDAQ:JAZZ ) shareholders haven't noticed that the Senior VP & Chief...
NasdaqGM:STSA
NasdaqGM:STSA
NasdaqGM:STSAPharmaceuticals

Here's Why We're Watching Satsuma Pharmaceuticals' (NASDAQ:STSA) Cash Burn Situation

May 13, 2022
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
NasdaqGS:AVIR
NasdaqGS:AVIR
NasdaqGS:AVIRPharmaceuticals

Atea Pharmaceuticals, Inc.'s (NASDAQ:AVIR) Shares Not Telling The Full Story

May 13, 2022
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 16x, you may...
NasdaqGS:TARS
NasdaqGS:TARS
NasdaqGS:TARSPharmaceuticals

Need To Know: Analysts Are Much More Bullish On Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Revenues

May 13, 2022
Shareholders in Tarsus Pharmaceuticals, Inc. ( NASDAQ:TARS ) may be thrilled to learn that the analysts have just...
NasdaqGM:OCUL
NasdaqGM:OCUL
NasdaqGM:OCULPharmaceuticals

Some Analysts Just Cut Their Ocular Therapeutix, Inc. (NASDAQ:OCUL) Estimates

May 13, 2022
One thing we could say about the analysts on Ocular Therapeutix, Inc. ( NASDAQ:OCUL ) - they aren't optimistic, having...
NasdaqGM:HROW
NasdaqGM:HROW
NasdaqGM:HROWPharmaceuticals

Does Harrow Health (NASDAQ:HROW) Have A Healthy Balance Sheet?

May 12, 2022
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
NasdaqGS:JAZZ
NasdaqGS:JAZZ
NasdaqGS:JAZZPharmaceuticals

Jazz Pharmaceuticals (NASDAQ:JAZZ) Takes On Some Risk With Its Use Of Debt

May 12, 2022
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
NasdaqCM:DRRX
NasdaqCM:DRRX
NasdaqCM:DRRXPharmaceuticals

Is DURECT (NASDAQ:DRRX) A Risky Investment?

May 12, 2022
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
NasdaqGS:INVA
NasdaqGS:INVA
NasdaqGS:INVAPharmaceuticals

Innoviva, Inc. (NASDAQ:INVA) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

May 12, 2022
With its stock down 21% over the past month, it is easy to disregard Innoviva (NASDAQ:INVA). However, stock prices are...
Last
  • 1
  • 2
  • 3
  • 4
  • 5
Next

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.

Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
  • About
  • Company
  • Careers
  • Plans
  • Log In
  • Help Centre
  • Latest Coverage
  • Podcasts
  • Financial Services Guide
  • Terms and Conditions
  • Privacy Policy

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.